SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

263 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55,217,286 shares of 56,047,431 outstanding shares and own 98.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,451,022 shares), VANGUARD GROUP INC (5,513,149 shares), ARMISTICE CAPITAL, LLC (4,136,000 shares), DIMENSIONAL FUND ADVISORS LP (2,240,621 shares), MACQUARIE GROUP LTD (2,171,428 shares), GW&K Investment Management, LLC (1,836,466 shares), STATE STREET CORP (1,782,857 shares), LOOMIS SAYLES & CO L P (1,671,214 shares), Stephens Investment Management Group LLC (1,577,980 shares), and Aristotle Capital Boston, LLC (1,285,872 shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.